Literature DB >> 8287223

Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas.

M Noguchi1, N Maezawa, Y Nakanishi, Y Matsuno, Y Shimosato, S Hirohashi.   

Abstract

The p53 gene mutation pattern was used as a diagnostic marker of multiple and second primary lung carcinomas. Nine cases of multiple carcinoma, which were suspected clinicopathologically to be double or triple primary carcinomas, were examined for p53 protein expression by immunohistochemistry and for genetic abnormality of the p53 gene by polymerase chain reaction (PCR)-single-strand conformation polymorphism (SSCP) analysis. Nine tumors from four cases gave a positive result upon both immunostaining for the p53 protein and PCR-SSCP analysis of the p53 gene. These nine tumors showed different mobility shifts between exons 5 and 8. The four cases were diagnosed genetically as multiple primary carcinomas. To confirm the results of PCR-SSCP analysis, five tumors from two cases that showed different mobility shifts were further analyzed for their nucleotide sequences, and it was found that all of them had point mutations at different codons in exons 5 and 8. These findings suggest that the p53 gene mutation pattern is an effective marker for diagnosis of tumor multiplicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287223

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  10 in total

1.  Higher Level of P-glycoprotein Expression in Human Breast Cancer Cells after Radiation Therapy.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

2.  Determination of primary foci of metastatic tumors by p53 mutational analysis in intraesophageal multiple carcinomas.

Authors:  S Kuwabara; T Nishimaki; Y Ajioka; S Komukai; T Suzuki; H Watanabe; K Hatakeyama
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

3.  Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient.

Authors:  M Noguchi; S Hirohashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

4.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

5.  Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.

Authors:  Tomoki Yamano; Eiichi Morii; Isao Arai; Toshiaki Takada; Ken Kubota; Masahiko Sato; Takaaki Inoue; Yoshihiro Okada; Takahiko Hara; Katsuyuki Aozasa
Journal:  Int J Clin Oncol       Date:  2010-06-01       Impact factor: 3.402

6.  Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.

Authors:  R J Koness; T C King; S Schechter; S F McLean; C Lodowsky; H J Wanebo
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

7.  Patterns of p53 mutations in squamous cell carcinoma of the lung. Acquisition at a relatively early age.

Authors:  J Zheng; Q Shu; Z H Li; J I Tsao; L M Weiss; D Shibata
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Monoclonality of atypical adenomatous hyperplasia of the lung.

Authors:  S Niho; T Yokose; K Suzuki; T Kodama; Y Nishiwaki; K Mukai
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

9.  A novel somatic point mutation of the RET Proto-oncogene in tumor tissues of small cell lung cancer patients.

Authors:  H Futami; S Egawa; T Tsukada; K Maruyama; S Bandoh; M Noguchi; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1995-12

10.  Microsatellite instability and frameshift mutations in the Bax gene in hereditary nonpolyposis colorectal carcinoma.

Authors:  Y Sakao; M Noro; S Sekine; M Nozue; S Hirohashi; T Itoh; M Noguchi
Journal:  Jpn J Cancer Res       Date:  1998-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.